Lantheus estende moly o contrato com Nordion
por Brendon Nafziger, DOTmed News Associate Editor | January 05, 2011
Lantheus Medical Imaging said Wednesday it extended its contract with medical isotope supplier Nordion through 2013.
Originally, the deal to supply N. Billerica, Mass.-based Lantheus with molybdenum-99 was set to expire at the end of July.
Lantheus CEO and president Don Kiepert said the arrangement with Ottawa-based Nordion follows the company's policy of diversifying sourcing of Mo-99, which is only produced by a handful of reactors around the world. Last year, the shutdown of two aging reactors in the Netherlands and Canada for repairs led to global shortages of the isotope.
Mo-99 is the parent isotope of technetium-99m, widely used in nuclear medicine scans of the heart. Lantheus sells generators that milk Mo-99 into its daughter isotope.
Originally, the deal to supply N. Billerica, Mass.-based Lantheus with molybdenum-99 was set to expire at the end of July.
Lantheus CEO and president Don Kiepert said the arrangement with Ottawa-based Nordion follows the company's policy of diversifying sourcing of Mo-99, which is only produced by a handful of reactors around the world. Last year, the shutdown of two aging reactors in the Netherlands and Canada for repairs led to global shortages of the isotope.
Quality, speed, and peace of mind
GE HealthCare’s Repair Center Solutions are an ideal complement to your in-house service team. We service a broad range of mobile devices, including monitors and cardiology devices, parts, and portable ultrasound systems and probes.
